中国心血管病一级预防指南

2020-12-30 中华医学会心血管病学分会 中华心血管病杂志.2020.48(12)1000-1038.

心血管病是我国人群的首位死亡原因。实践证明,以生活方式干预和危险因素防控为核心的心血管病一级预防可有效延缓或避免心血管事件的发生。为全面推广健康生活方式并进一步规范高血压、血脂异常和糖尿病等心血管病危

中文标题:

中国心血管病一级预防指南

发布日期:

2020-12-30

简要介绍:

心血管病是我国人群的首位死亡原因。实践证明,以生活方式干预和危险因素防控为核心的心血管病一级预防可有效延缓或避免心血管事件的发生。为全面推广健康生活方式并进一步规范高血压、血脂异常和糖尿病等心血管病危险因素的检出、诊断和治疗,提高心血管病一级预防的整体水平,由中华医学会心血管病学分会牵头组织国内多学科专家,遵循国内外指南撰写规范,汇总评价最新研究证据并参考相关指南,最终形成适合我国人群的心血管病一级预防的推荐意见。该指南包括前言、指南制定的方法学、心血管病流行病学现状、一级预防的总体建议、心血管病风险评估、生活方式干预、血脂管理、血压管理、2型糖尿病管理以及阿司匹林的使用10部分内容。该指南的颁布和实施将为推进我国心血管病预防实践发挥积极作用。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (24)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2194494, encodeId=454c21944941c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb85424705, createdName=ms5000000000100156, createdTime=Thu Mar 21 16:17:59 CST 2024, time=2024-03-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1085446, encodeId=85e8108544656, content=怎么样才能下载呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 29 14:19:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197800, encodeId=2387119e80042, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc3d2404229, createdName=1235fbe8m37(暂无昵称), createdTime=Sun Feb 27 19:13:39 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188580, encodeId=a0521188580f2, content=學習了,謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e756484971, createdName=ms9000001768581926, createdTime=Thu Jan 27 13:52:16 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070656, encodeId=639b10e06563c, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Tue Nov 16 08:59:28 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2024-03-21 ms5000000000100156 来自山西省

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2194494, encodeId=454c21944941c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb85424705, createdName=ms5000000000100156, createdTime=Thu Mar 21 16:17:59 CST 2024, time=2024-03-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1085446, encodeId=85e8108544656, content=怎么样才能下载呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 29 14:19:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197800, encodeId=2387119e80042, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc3d2404229, createdName=1235fbe8m37(暂无昵称), createdTime=Sun Feb 27 19:13:39 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188580, encodeId=a0521188580f2, content=學習了,謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e756484971, createdName=ms9000001768581926, createdTime=Thu Jan 27 13:52:16 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070656, encodeId=639b10e06563c, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Tue Nov 16 08:59:28 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-12-29 ms4000000901131801

    怎么样才能下载呢

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2194494, encodeId=454c21944941c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb85424705, createdName=ms5000000000100156, createdTime=Thu Mar 21 16:17:59 CST 2024, time=2024-03-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1085446, encodeId=85e8108544656, content=怎么样才能下载呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 29 14:19:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197800, encodeId=2387119e80042, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc3d2404229, createdName=1235fbe8m37(暂无昵称), createdTime=Sun Feb 27 19:13:39 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188580, encodeId=a0521188580f2, content=學習了,謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e756484971, createdName=ms9000001768581926, createdTime=Thu Jan 27 13:52:16 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070656, encodeId=639b10e06563c, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Tue Nov 16 08:59:28 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-02-27 1235fbe8m37(暂无昵称)

    学习了,谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2194494, encodeId=454c21944941c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb85424705, createdName=ms5000000000100156, createdTime=Thu Mar 21 16:17:59 CST 2024, time=2024-03-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1085446, encodeId=85e8108544656, content=怎么样才能下载呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 29 14:19:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197800, encodeId=2387119e80042, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc3d2404229, createdName=1235fbe8m37(暂无昵称), createdTime=Sun Feb 27 19:13:39 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188580, encodeId=a0521188580f2, content=學習了,謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e756484971, createdName=ms9000001768581926, createdTime=Thu Jan 27 13:52:16 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070656, encodeId=639b10e06563c, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Tue Nov 16 08:59:28 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-01-27 ms9000001768581926

    學習了,謝謝

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2194494, encodeId=454c21944941c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cb85424705, createdName=ms5000000000100156, createdTime=Thu Mar 21 16:17:59 CST 2024, time=2024-03-21, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=1085446, encodeId=85e8108544656, content=怎么样才能下载呢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12cb5438026, createdName=ms4000000901131801, createdTime=Wed Dec 29 14:19:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197800, encodeId=2387119e80042, content=学习了,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc3d2404229, createdName=1235fbe8m37(暂无昵称), createdTime=Sun Feb 27 19:13:39 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188580, encodeId=a0521188580f2, content=學習了,謝謝, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e756484971, createdName=ms9000001768581926, createdTime=Thu Jan 27 13:52:16 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070656, encodeId=639b10e06563c, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Tue Nov 16 08:59:28 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-16 1e22b426m70(暂无匿称)

    好文

    0

拓展阅读

2015 AHA科学声明:遗传学和基因组学心血管病临床应用与基本概念

美国心脏协会(AHA,American Heart Association) · 2015-01-05

2016 AHA/ACC/AGS 科学声明:高龄患者心血管病治疗知识缺陷

美国心脏病学会(ACC,American College of Cardiology) · 2016-04-11

2016 CCS指南:血脂异常管理预防成人心血管病

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2016-07-25

2017 SCAI/HFSA专家共识:应用侵入性血流动力学检查诊断和管理心血管病(摘要)

美国心血管造影和介入学会(SCAI,Society for Cardiovascular Angiography and Interventions) · 2017-05-10

基层心血管病综合管理实践指南2020

北京高血压防治协会(BHA) · 2020-08-20